24 Apr 2019

CHRONIC PAIN PATIENTS PUNISHED FOR OPIOID ABUSE BY DOCTORS, PHARMACIES, PAIN CLINICS; GOVERNMENT OVER REACTS

By Blake Farmer Nashville Public Radio A pharmacist in Celina, Tenn., was one of 60 people indicted on charges of opioid-related crimes in April  in a multistate sting. John Polston was charged with 21 counts of filling medically unnecessary narcotic prescriptions. He was also Gail Gray’s pharmacist and the person she relied

0
10 Apr 2019

LETHAL PLANS: When seniors turn to suicide in long-term care

      By Melissa Bailey and JoNel Aleccia When Larry Anders moved into the Bay at Burlington nursing home in late 2017, he wasn’t supposed to be there long. At 77, the stoic Wisconsin machinist had just endured the death of his wife of 51 years and a grim new diagnosis: throat

0
09 Apr 2019

 MERZ NORTH AMERICA REGAINS EXCLUSIVE DISTRIBUTION OF ASCLERA (POLIDOCANOL) INJECTION

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able

0
28 Mar 2019

A NEW RF SYSTEM: VENCLOSE 2ND GENERATION RADIOFREQUENCY TECHNOLOGY OUTPERFORMS LEGACY SYSTEM

    By Larry Storer The great medical technology companies of our time start and develop in a variety of ways. Some start with a product or idea and built a market around it. Some start as spinoffs from existing successful companies. But Venclose started by determining the unmet needs

0
28 Mar 2019

SIGVARIS CHANGES CORPORATE NAME, LOGO

        SIGVARIS has changed its corporate name from SIGVARIS to SIGVARIS GROUP and has also changed its logo. SIGVARIS has a 150-year history of proven success, according to CEO Mark Bunker. “We are the world leader in medical compression socks and hosiery with a wide assortment of

0
28 Mar 2019

Virtual reality immerses physicians in AVLS education offerings

By Ron Seybold The American Vein and Lymphatic Society is launching a new project to use immersive virtual reality (VR) technology for its educational courses. The educational an array of venous medicine techniques. VR has started to make it possible to gain a better view than ever of fundamental and cutting-edge

0
28 Mar 2019

DU STUDIES ILIOCAVAL STENT

DU STUDIES ILIOCAVAL STENT Duplex Ultrasound improves treatment of femoro-iliocaval occlusive venous disease   By Jan M. Sloves, RVT and Jose I Almeida, MD   The last two decades have witnessed a great increase in stent treatment for femoro-iliocaval occlusive venous disease. We know from previous reports that the major

0
15 Mar 2019

AVLS HOSTS Virtual Reality-BASED COURSE ON SCLEROTHERAPY

The American Vein & Lymphatic Society is offering a full day course on sclerotherapy featuring its new virtual reality hands-on training. The sclerotherapy course will be offered at 8 a.m. April 6 at the Sheraton Suites Chicago O’Hare in Rosemont, Illinois.             Register at phleboloy.org.

0
14 Mar 2019

STAINING MAY OCCUR AFTER SCLEROTHERAPY

    By Ronald F. Bush, MD, FACS and Peggy Bush, APRN Staining (hemosiderin deposition) after sclerotherapy is not infrequent. Staining results from trapped blood that occurs after sclerotherapy injections or red cell extravasation. All vessels will clot to some degree unless methods are taken to minimize clotting at the

0
14 Mar 2019

PCF OR ‘FOAM IN A CAN.’ READ THE STUDY AND YOU DECIDE

Roger Hogue, MD, has conducted a new study that makes the case that PCF foam structure and visual foam quality is as good or better than proprietary “Foam in a Can.” Whether you prefer to buy the foam you use or whether you prefer to compound it, this detailed study

0